Perinatal depression, anxiety and intimacy

Mood and anxiety conditions in pregnancy and the first postnatal year are common, treatable, and among the strongest predictors of sexual difficulty in new parents — more so than the physical recovery.

Prevalence

• Postnatal depression affects around 10–15% of birthing parents; perinatal anxiety affects a similar or slightly higher proportion, and the two frequently occur together.
• Paternal/non-birthing-parent depression affects roughly 8–10% in the first year (Paulson & Bazemore, JAMA, 2010 meta-analysis), rising when the other parent is depressed. It is rarely screened for.
• Birth-related PTSD affects around 4% of births overall, and 15–19% after a birth experienced as traumatic (Yildiz et al., 2017 meta-analysis).
• Postpartum psychosis is rare — about 1–2 per 1,000 births — but is a psychiatric emergency, with onset usually in the first two weeks.

How it affects intimacy

• Reduced desire is a core symptom of depression itself, not a separate problem to solve.
• Trauma from birth can make vaginal examination, penetration or even undressing feel unsafe; avoidance and hypervigilance are PTSD features, not reluctance.
• Anxiety and sleep deprivation raise cortisol and reduce capacity for the arousal window; responsive rather than spontaneous desire is the norm in this period (see models of sexual response).
• Antidepressants themselves affect sexual function: SSRIs cause delayed orgasm or reduced desire in a substantial proportion. This is manageable — dose change, timing, switching to bupropion or mirtazapine — and is a reason to tell your prescriber, not to stop medication abruptly.

Screening and treatment

• The Edinburgh Postnatal Depression Scale (EPDS) is the standard screening tool; a score of 13 or more warrants assessment, and item 10 (self-harm thoughts) is acted on at any score.
• Psychological therapy is first-line for mild to moderate symptoms (NICE CG192): CBT, interpersonal therapy, and guided self-help all have trial support.
• Antidepressants in breastfeeding: sertraline and paroxetine have the lowest measured infant plasma levels and are usually preferred. NICE and the UK Drugs in Lactation Advisory Service support continuing effective treatment rather than stopping to breastfeed.
• Brexanolone and zuranolone are licensed in the US specifically for postpartum depression, with rapid onset; zuranolone (approved 2023) is an oral 14-day course.
• Trauma-focused CBT and EMDR are effective for birth-related PTSD; a birth reflections or debrief service can help but is not a substitute for therapy.

Rebuilding intimacy

• Separate affection from sex explicitly for a period — scheduled non-sexual touch (the Sensate Focus approach) has the best evidence base for re-establishing contact without performance pressure.
• Name what has changed out loud. Cohort data consistently shows couples who discuss postnatal sexual change report higher satisfaction than those who wait for it to resolve.
• Address the physical contributors in parallel — lubrication, pelvic floor, scar pain — because untreated pain reinforces avoidance.
• Sleep protection is a genuine intervention: alternating night duty produces measurable mood improvement in trials of postnatal sleep support.

Urgent — get help today

• Thoughts of harming yourself or the baby
• Confusion, not sleeping at all, hearing or believing things others do not (possible postpartum psychosis — this is an emergency)
• Feeling unable to keep yourself or your baby safe

In the US call or text 988; in the UK call 111 or your maternity unit; in an emergency call 999/911.

Sources

• NICE CG192, Antenatal and Postnatal Mental Health, 2014 (updated 2020).
• Paulson JF & Bazemore SD, JAMA, 2010 (paternal depression meta-analysis).
• Yildiz PD et al., Journal of Affective Disorders, 2017 (birth-related PTSD prevalence).
• Cox JL et al., EPDS, British Journal of Psychiatry, 1987.
• Deligiannidis KM et al., American Journal of Psychiatry, 2023 (zuranolone trial).